GENERAL THORACIC SURGERY: Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology

GENERAL THORACIC SURGERY: Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology is organized by The Society of Thoracic Surgeons (STS).

Release Date: Jan 01, 2019
Expiry Date: Jan 01, 2021

Accreditation: 1.0 AMA PRA Category 1 Credit ™

Description:
Each STS CME activity in The Annals consists of a self-study test on an original article from one of the journal's major subject categories (Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Cardiothoracic Anesthesiology), a statement of the learning objectives and an evaluation of the activity.

Learning Objective:
After reading this article, the learner should be able to:
• identify the choices of induction therapy for esophageal cancer patients prior to esophagectomy.
• recognize that histology may be important in the decision to provide induction therapy.
• identify the characteristics of the esophageal cancer patient that may be treated with induction therapy.
• identify the expected short and long term outcomes for esophageal cancer patients treated with esophagectomy after induction therapy.